Dopamine receptor-interacting proteins: The Ca2+ connection in dopamine signaling

Trends in Pharmacological Sciences

Volumn 24, Issue 9, 2003, Pages 486-492

  Bergson, Clare ^a   Levenson, Robert ^b   Goldman Rakic, Patricia S ^c   Lidow, Michael S ^d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR INTERACTING PROTEIN; DOPAMINE RECEPTOR STIMULATING AGENT; PROTEIN; UNCLASSIFIED DRUG;

CALCIUM SIGNALING; COHORT ANALYSIS; CYTOSKELETON; DOPAMINE BRAIN LEVEL; HOMEOSTASIS; HUMAN; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 0042880916     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00232-3     Document Type: Review

References (80)

1. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv. Pharmacol. 42:1998;707-711.
2. Schultz W. Getting formal with dopamine and reward. Neuron. 36:2002;241-263.
3. Yelnik J. Functional anatomy of the basal ganglia. Mov. Disord. 17:(Suppl. 3):2002;S15-S21.
4. Arnsten A.F. Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog. Brain Res. 126:2000;183-192.
5. Volkow N.D., et al. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav. Pharmacol. 13:2002;355-366.
6. Swerdlow N.R., Koob G.F. Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-palido-thalamic function. Behav. Brain Sci. 10:1987;197-245.
7. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav. Brain Res. 130:2002;65-71.
8. Muller-Vahl K.R. The treatment of Tourette's syndrome: current opinions. Expert Opin. Pharmacother. 3:2002;899-914.
9. Nicola S.M., et al. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci. 23:2000;185-215.
10. Missale C., et al. Dopamine receptors: from structure to function. Physiol. Rev. 78:1998;189-225.
11. Wang Q., et al. Dependence of D1 dopamine receptor activation on G protein γ7 subunit. J. Biol. Chem. 276:2001;39386-39393.
12. Rocheville M., et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science. 288:2000;154-157.
13. Scarselli M., et al. Dopamine D2 and D3 receptor heterodimers exhibit unique functional properties. J. Biol. Chem. 276:2001;30308-30314.
14. Nimchinsky E.A., et al. Expression of dopamine D3 dimers and tetramers in brain and in transfected cells. J. Biol. Chem. 272:1997;29229-29237.
15. Lee F.J., et al. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell. 111:2002;219-230.
16. Fiorentini C., et al. (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D aspartate receptors. J. Biol. Chem. 278:2003;20196-20202.
17. Gines S., et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8606-8611.
18. Hillion J., et al. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 277:2002;18091-18097.
19. Liu F., et al. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature. 403:2000;274-280.
20. Lavine N., et al. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 277:2002;46010-46019.
21. Bermak J.C., et al. Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 3:2001;492-498.
22. Bermak J.C., et al. Interaction of gamma-COP with a transport motif in the D1 receptor C-terminus. Eur. J. Cell Biol. 81:2002;77-85.
23. Li M., et al. Modulation of dopamine D(2) receptor signaling by actin-binding protein (ABP-280). Mol. Pharmacol. 57:2000;446-452.
24. Lin R., et al. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with Filamin A. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5258-5263.
25. Kim O.J., et al. Neurofilament-M interacts with the D1 dopamine receptor to regulate cell surface expression and desensitization. J. Neurosci. 22:2002;5920-5930.
26. Binda A.V., et al. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. Mol. Pharmacol. 62:2002;507-513.
27. Oldenhof J., et al. SH3 binding domains in the dopamine D4 receptor. Biochemistry. 37:1998;15726-15736.
28. Oldenhof J., et al. SH3 ligands in the dopamine D3 receptor. Cell. Signal. 13:2001;411-416.
29. Kabbani N., et al. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J. Neurosci. 22:2002;8476-8486.
30. Lezcano N., et al. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science. 287:2000;1660-1664.
31. Smith F.D., et al. Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. J. Biol. Chem. 274:1999;19894-19900.
32. Sabatini B.L., et al. Ca(2+) signaling in dendritic spines. Curr. Opin. Neurobiol. 11:2001;349-356.
33. Saberan-Djoneidi D., et al. A 19-kDa protein belonging to a new family is expressed in the Golgi apparatus of neural cells. J. Biol. Chem. 270:1995;1888-1893.
34. Saberan-Djoneidi D., et al. A 21-kDa polypeptide belonging to a new family of proteins is expressed in the Golgi apparatus of neural and germ cells. J. Biol. Chem. 273:1998;3909-3914.
35. Steiner P., et al. Modulation of receptor cycling by neuron-enriched endosomal protein of 21 kD. J. Cell Biol. 157:2002;1197-1209.
36. Undie A.S., et al. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J. Neurochem. 62:1994;2045-2048.
37. Felder C.C., et al. Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes. J. Biol. Chem. 25:1989;8739-8745.
38. Nowicki S., et al. Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells. Am. J. Physiol. Cell Physiol. 279:2000;C1812-C1818.
39. Lidow M.S., et al. Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors. Eur. J. Pharmacol. 427:2001;187-193.
40. Holst B., et al. Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J. Biol. Chem. 276:2001;19793-19799.
41. Bergson C., et al. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15:1995;7821-7836.
42. Lezcano N., Bergson C. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J. Neurophysiol. 87:2002;2167-2175.
43. Yeckel M.F., et al. Multiple forms of LTP in hippocampal CA3 neurons use a common postsynaptic mechanism. Nat. Neurosci. 2:1999;625-633.
44. Finch E.A., Augustine G.J. Local calcium signalling by inositol-1,4,5-trisphosphate in Purkinje cell dendrites. Nature. 396:1998;753-756.
45. Raymond C.R., et al. Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation. J. Neurosci. 20:2000;969-976.
46. Korkotian E., Segal M. Release of calcium from stores alters the morphology of dendritic spines in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12068-12072.
47. Hashimoto K., et al. Roles of phospholipase Cbeta4 in synapse elimination and plasticity in developing and mature cerebellum. Mol. Neurobiol. 23:2001;69-82.
48. Rodrigues P.S., Dowling J.E. Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. Proc. Natl. Acad. Sci. U. S. A. 87:1990;9693-9697.
49. Wu G.Y., Cline H.T. Stabilization of dendritic arbor structure in vivo by CaMKII. Science. 279:1998;222-226.
50. Redmond L., et al. Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription. Neuron. 34:2002;999-1010.
51. Braunewell K.H., Gundelfinger E.D. Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium-binding proteins in search of a function. Cell Tissue Res. 295:1999;1-12.
52. Tsujimoto T., et al. Neuronal calcium sensor 1 and activity-dependent facilitation of P/Q-type calcium currents at presynaptic nerve terminals. Science. 295:2002;2276-2279.
53. Pan C.Y., et al. Alterations in exocytosis induced by neuronal Ca2+ sensor-1 in bovine chromaffin cells. J. Neurosci. 22:2002;2427-2433.
54. Taverna E., et al. Neuronal calcium sensor 1 and phosphatidylinositol 4-OH kinase beta interact in neuronal cells and are translocated to membranes during nucleotide-evoked exocytosis. J. Cell Sci. 115:2002;3909-3922.
55. Martone M.E., et al. Cellular and subcellular distribution of the calcium-binding protein in the central nervous system of the rat. Cell Tissue Res. 295:1999;395-407.
56. Cox J.A., et al. Cation binding and conformational changes in VILIP and two neuron-specific calcium- binding proteins. J. Biol. Chem. 269:1994;32807-32813.
57. Yazejian B., et al. Tracking presynaptic Ca2+ dynamics during neurotransmitter release with Ca2+- activated K+ channels. Nat. Neurosci. 3:2000;566-571.
58. Pongs O., et al. Frequenin, a novel calcium-binding protein that modulates synaptic efficacy in the drosophila nervous system. Neuron. 11:1993;15-28.
59. Olafsson P., et al. Molecular cloning and functional characterization of the Xenopus Ca(2+)- binding protein frequenin. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8001-8005.
60. Kabbani, N., and Levenson, R. (2002) A role for the neuronal calcium sensor NCS-1 in modulating GRK-mediated desensitization of the D2 receptor. Program No. 542.2 Abstract Viewer/Itinerary Planner, Society for Neuroscience 2002
61. Koh P.O., et al. Upregulation of the d1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. Arch. Gen. Psychiatry. 60:2003;311-319.
62. Koh P.O., et al. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc. Natl. Acad. Sci. U. S. A. 100:2003;313-317.
63. Carlsson A., et al. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41:2001;237-260.
64. Weinberger D.R., et al. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry. 50:2001;825-844.
65. Gao W.J., et al. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc. Natl. Acad. Sci. U. S. A. 98:2001;295-300.
66. Gao W.-J., Goldman-Rakic P.S. Selective modulation of excitatory and inhibitory microcircuits by dopamine. Proc. Natl. Acad. Sci. U. S. A. 100:2003;2836-2841.
67. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
68. Okubo Y., et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 385:1997;634-636.
69. Abi-Dargham A., et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 22:2002;3708-3719.
70. Sczekan S.R., Strumwasser F. Antipsychotic drugs block IP3-dependent Ca(2+)-release from rat brain microsomes. Biol. Psychiatry. 40:1996;497-502.
71. Potkin S.G., et al. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol. Psychiatry. 8:2003;109-113.
72. Weinberger D.R., Berman K.F. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr. Bull. 14:1988;157-168.
73. Suhara T., et al. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch. Gen. Psychiatry. 59:2002;25-30.
74. Arana G.W., et al. Handbook of Psychiatric Drug Therapy. 4th Edn :2000;Lippincott Wiliams & Wikins.
75. Taylor M.A., Amir N. Are schizophrenia and affective disorder related?: the problem of schizoaffective disorder and the discrimination of the psychoses by signs and symptoms. Comp. Psychiatry. 35:1994;420-429.
76. Fisher S.E., et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 70:2002;1183-1196.
77. Lazar J.W., Frank Y. Frontal systems dysfunction in children with attention-deficit/hyperactivity disorder and learning disabilities. J. Neuropsychiatry Clin. Neurosci. 10:1998;160-167.
78. Erlenmeyer-Kimling L., et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am. J. Psychiatry. 157:2000;1416-1422.
79. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature. 422:2003;198-207.
80. Ewald H., et al. Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. Am. J. Med. Genet. 114:2002;196-204.